NCT00221026 - Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Crohn's Disease

Interventions

DRUG

Methoxsalen +ECP

ECP + Uvadex given at weeks 1-12 weeks.

PROCEDURE

Extracorporeal Photopheresis

ECP given at weeks 1 through 12.

Trial Locations (15)

NIH, Bethesda

Metropolitian Gastroenterology Group, Chevy Chase

Morristown Memorial Hospital, Morristown

Mount Sinai Medical Center, New York

General Hospital of Vienna, Vienna

Hospital Erasme/ULB, Brussels

UZ Leuven, Leuven

Universitat St Josef, Bochum

Krankenhaus Duren gem.GmbH, Düren

Universitatsklinik Essen, Essen

Universitatsklinikum, Jena

Universitatsklinikum Mannheim, Mannheim

University Hospital Munich-Grosshadem, Munich

Klinikum Oldenberg, Oldenburg

Medizinische Universitatsklinik Ulm, Ulm